Potential treatment modalities for glaucomatous neuropathy: Neuroprotection and neuroregeneration

Journal of Glaucoma

Volumn 5, Issue 6, 1996, Pages 427-432

  Schwartz, Michal ^a   Belkin, Michael ^b   Yoles, Eti ^a   Solomon, Arieh ^b  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Animal models; Glaucoma; Neurodegeneration; Neuropathy; Neuroprotection; Neuroregeneration; Therapy

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CRUSH TRAUMA; GLAUCOMA; HUMAN; NERVE DEGENERATION; NEUROPATHY; NEUROPROTECTION; OPTIC NERVE; OPTIC NERVE FIBER; OPTIC NERVE LESION; PRIORITY JOURNAL; RAT;

ANIMALS; CELL SURVIVAL; DISEASE MODELS, ANIMAL; GLAUCOMA, OPEN-ANGLE; HUMANS; NERVE FIBERS; NERVE REGENERATION; OPTIC DISK; OPTIC NERVE; OPTIC NERVE DISEASES; RETINAL GANGLION CELLS;

EID: 0029904475     PISSN: 10570829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. van Buskirk EM, Cioffi GA. Predicted outcome from hypotensive therapy for glaucomatous optic neuropathy. Am J Ophthalmol 1993;125:636-40.
2. Fechtner RD, Weinreb RN. Mechanisms of optic nerve damage in glaucoma. Surv Ophthalmol 1994;39:23-42.
3. Harris A, Sergott RG, Spaeth GL, Katz JL, Shoemaker JA, Martin BJ. Color Doppler analysis for ocular blood velocity in normal tension glaucoma. Am J Ophthalmol 1994;118:642-9.
4. Duvdevani R, Rosner M, Belkin M, Sautter J, Sabel BA, Schwartz M. Graded crush of the rat optic nerve as a brain injury model: combining electrophysiological and behavioral outcome. Restorative Neurol Neurosci 1990;2:31-8.
5. 1 ganglioside treatment reduces visual deficits after graded crush of the rat optic nerve. Brain Res 1991;565:23-33.
6. 1 reduces early injury-induced metabolic deficits and subsequent degeneration in the rat optic nerve. Invest Ophthalmol 1992;83:3586-91.
7. Yoles E, Belkin M, Schwartz M. HU-211, a nonpsychotropic cannabinoid, produces a short- and long-term neuroprotein after optic nerve axotomy. J Neurotrauma 1996;13:49-57.
8. Lampen PW, Vogel MH, Zimmerman LE. Pathology of the optic nerve in experimental acute glaucoma: electron microscopic studies. Invest Ophthalmol 1968;7:199-213.
9. Quigley HA, Anderson DR. The dynamics and location of axonal transport blockade by acute intraocular pressure elevation in primate optic nerve. Invest Ophthalmol 1976;15:606-16.
10. Minckler DS, Bunt AH, Johanson GW. Orthograde and retrograde axoplasmic transport during acute ocular hypertension in the monkey. Invest Ophthalmol Vis Sci 1977;16:426-41.
11. Minckler DS, Bunt AH, Klock IB. Radioautographic and cytochemical ultrastructural studies of axoplasmic transport in the monkey optic nerve head. Invest Ophthalmol Vis Sci 1978;17:33-50.
12. Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 1994;25:431-8.
13. Villegas-Pérez MP, Vidal-Sanz M, Rasminsky M, Bray GM, Aguayo AJ. Rapid and protracted phases of retinal ganglion cell loss follows axotomy in the optic nerve of adult rat. J Neurobiol 1993;24:23-36.
14. Quigley HA, Nickells RW, Kerrigan LA, Pease ME, Thibault DJ, Zack DJ. Retinal ganglion cell death in experimental glaucoma and after axotomy occurs by apoptosis. Invest Ophthalmol Vis Sci 1995;36:774-86.
15. Gaasterland D, Tanishima T, Kuwabara T. Axoplasmic flow during chronic experimental glaucoma: I. Light and electron microscopic studies of the monkey optic nerve head during development of glaucomatous cupping. Invest Ophthalmol Vis Sci 1978;17:838-46.
16. Quigley HA, Addicks EM. Chronic experimental glaucoma in primates: II. Effect of extended intraocular pressure elevation on optic nerve head and axonal transport. Invest Ophthalmol Vis Sci 1980;19:137-52.
17. Quigley HA, Addicks EM, Green WR, Maumenee AE. Optic nerve damage in human glaucoma: II. The site of injury and susceptibility to damage. Arch Ophthalmol 1981;99:635-49.
18. Caprioli J. Correlation of visual function with optic nerve and nerve fiber layer structures in glaucoma. Surv Ophthalmol 1989; 33(suppl):319-30.
19. Quigley HA, Dunkelberger GR, Green WR. Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989;107:453-64.
20. Sommer A, Katz J, Quigley HA, et al. Clinically detectable nerve fiber atrophy precedes the onset of glaucomatous field loss. Arch Ophthalmol 1991;109:77-83.
21. Kendall KR, Quigley HA, Kerrigan LA, Pease ME, Quigley EN. Primary open-angle glaucoma is not associated with photoreceptor loss. Invest Ophthalmol Vis Sci 1995;36:200-5.
22. Schumer RA, Podos SM, Lipton SA, Dryer EB. Increased glutamate in the vitreous of monkeys with induced glaucoma. Invest Ophthalmol Vis Sci 1994;35(suppl):1484.
23. Faden AI. Experimental neurobiology of central nervous system trauma. Crit Rev Neurobiol 1993;7:175-86.
24. Faden AI, Salzman S. Pharmacological strategies in CNS trauma. Trends Pharmacol Sci 1992;13:29-35.
25. Lipton SA. Molecular mechanisms of trauma-induced neuronal degeneration. Curr Opin Neurol Neurosurg 1993;6:588-96.
26. Siesjo BK. Basic mechanisms of traumatic brain damage. Ann Emerg Med 1993;22:959-69.
27. Masai H, Kaneda K, Kume T, et al. Release of glutamate and neurodegeneration induced by retinal ischemia. Invest Ophthalmol Vis Sci 1995;36(suppl):S934.
28. Schumer RA, Podos SM. The nerve of glaucoma! Arch Ophthalmol 1994;112:37-44.
29. Tsai CS, Shin DH, Wan JY, Zeiter JH. Visual field global indices in patients with reversal of glaucomatous cupping after intraocular pressure reduction. Ophthalmology 1991;98:1412-9.
30. Peruche B, Krieglstein J. Mechanisms of drug actions against neuronal damage caused by ischemia: an overview. Prog Neuropsychopharmacol Biol Psychiatry 1993;17:21-70.
31. Fisher M, Jonas S, Sacco RL. Prophylactic neuroprotection for cerebral ischemia. Stroke 1994;25:1075-80.
32. Dreyer EB, Pan ZH, Storm S, Lipton SA. Greater sensitivity of larger retinal ganglion cells to NMDA-mediated cell death. Neuroreport 1994;5:629-31.
33. Netland PA, Chaturvedi N, Dreyer EB. Calcium channel blocker in the management of low tension and open-angle glaucoma. Am J Ophthalmol 1993;125:608-13.
34. Lombardi G, Moroni F, Moroni F. Glutamate-receptor antagonists protect against ischemia-induced retinal damage. Eur J Pharmacol 1994;271:489-95.
35. Takahashi K, Lam TT, Edward DP, Buchi ER, Tso MM. Protective effects of flunarizine on ischemic injury in the rat retina. Arch Ophthalmol 1992;110:862-70.
36. El-Asrar AMB, Morse PH, Maimone D, Torczynski E, Reder AT. MK-801 protects retinal neurons from hypoxia and the toxicity of glutamate and aspartate. Invest Ophthalmol Vis Sci 1992;33: 3463-8.
37. Eschweiler GW, Bahr M. Flunarizine enhances rat retinal ganglion cell survival after axotomy. J Neurol Sci 1993;116:34-40.
38. Goldstein LB. Basic and clinical studies of pharmacologic effects on recovery from brain injury. J Neural Transplant Plast 1993;4: 175-92.
39. Muir KW, Lees KR. Clinical experience with excitatory amino acid-antagonist drugs. Stroke 1995;26:503-13.
40. Scatton B. Excitatory amino acid-receptor antagonists: a novel treatment of ischemic cerebrovascular diseases. Life Sci 1994;55: 2115-24.
41. Stein DG, Glasier MM, Hoffman SW. Conceptual and practical issues in the pharmacological treatment of brain injury. J Neural Transplant Plast 1993;4:227-37.
42. Spoor TC, Hartel WC, Lensink DB, Wilkinson MJ. Treatment of traumatic optic neuropathy with corticosteroids. Am J Ophthalmol 1990;110:665-9.
43. García-Valenzuela E, Shareef S, Walsh J, Sharma SC. Programmed cell death of retinal ganglion cells during experimental glaucoma. Exp Eye Res 1995;61:33-44.
44. Núñez G, Merino R, Grillot D, González-García M. bcl-2 and bcl-x: regulatory switches for lymphoid death and survival. Immunol Today 1994;15:582-8.
45. Zhong L-T, Sarafian T, Kane DJ, et al. bcl-2 inhibits death of central neural cells induced by multiple agents. Proc Natl Acad Sci USA 1993;90:4533-7.
46. Bray GM, Villegas-Pérez MP, Vidal-Sanz M, Aguayo AJ. The use of peripheral nerve grafts to enhance neuronal survival promote growth and permit terminal reconnections in the central nervous system of adult rats. J Exp Biol 1987;132:5-19.
47. Vidal-Sanz M, Bray GM, Villegas-Pérez MP, Thanos S, Aguayo AJ. Axonal regeneration and synapse formation in the superior colliculus by retinal ganglion cells in the adult rat. J Neurosci 1987;7:2894-909.
48. Villegas-Pérez MP, Vidal-Sanz M, Bray GM, Aguayo AG. Influence of peripheral nerve grafts on the survival and regrowth of axotomized retinal cells in adult rats. J Neurosci 1988;8:265-80.
49. Cadelli DS, Schwab ME. Myelin-associated inhibitors of neurite outgrowth and their role in CNS regeneration. Ann NY Acad Sci 1991;633:234-40.
50. Schwab ME. Regeneration of lesioned CNS axons by neutralization of neurite growth inhibitors: a short review. J Neurotrauma 1992;9(suppl):S219-21.
51. Eitan S, Solomon A, Lavie V, et al. Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science 1994;264:1764-8.
52. Kiersted SA, Rasminsky M, Fukuda Y, Carter DA, Aguayo AJ, Vidal-Sanz M. Electrophysiologic responses in hamster superior colliculus evoked by regenerating retinal axons. Science 1989;246: 255-7.
53. Hirschberg DL, Yoles E, Belkih M, Schwartz M. Inflammation after axonal injury has conflicting consequences for recovery of function: rescue of spared axons is impaired but regeneration is supported. J Neuroimmunol 1994;50:9-16.
54. Danysz W, Parsons CG, Bresink I, Quack G. Glutamate in CNS disorders. Drug News Perspect 1995;8:262-77.
55. Moore CG, Milne ST, Morrison JC. A rat model of pressure-induced optic nerve damage. Invest Ophthalmol Vis Sci 1993;34: 1141.
56. Dwyer D, Bacon DR, Onda E, van Buskirk EM, Cioffi GA. Microvascular anatomy of the guinea pig optic nerve. Invest Ophthalmol Vis Sci 1994;35(suppl):1631.